Nature Search

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

In the first stage of the BR.36 adaptive trial in patients with non-small cell lung cancer receiving anti-PD1 immunnotherapy, the primary endpoint of concordance between circulating tumor DNA (ctDNA) molecular response and RECIST response was met. The results will inform the second, ctDNA-directed stage.

Valsamo Anagnostou
Cheryl Ho
Janet Dancey
ResearchOpen Access09 Oct 2023
Nature Medicine

Volume: 29, P: 2559-2569
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

Bhardwaj et al. report that adding Flt3 ligand to the treatment strategy effectively increased DC populations and increased T-cell responses in a randomized phase II trial of a DC-targeted vaccine for the melanoma antigen NY-ESO-1.

Nina Bhardwaj
Philip A. Friedlander
Steven P. Fling
Research16 Nov 2020
Nature Cancer

Volume: 1, P: 1204-1217
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage

Nelson Côrtes
Aline Lira
Gustavo Cabral-Miranda
ResearchOpen Access27 May 2025
npj Vaccines

Volume: 10, P: 1-12
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Munib Mesinovic
Xin Ci Wong
David Zucman
ResearchOpen Access16 Jul 2024
Scientific Reports

Volume: 14, P: 1-43
Unexpected malocclusion in a 13,000-Year-old Late Pleistocene young woman from Mexico

José Rubén Herrera-Atoche
James C. Chatters
Andrea Cucina
ResearchOpen Access07 Mar 2022
Scientific Reports

Volume: 12, P: 1-9
Rare CACNA1H and RELN variants interact through mTORC1 pathway in oligogenic autism spectrum disorder

André Luíz Teles e Silva
Talita Glaser
Andrea Laurato Sertié
ResearchOpen Access06 Jun 2022
Translational Psychiatry

Volume: 12, P: 1-11
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Ali Abbas
Sheryl Ann Abdukahil
Luis Felipe Reyes
ResearchOpen Access30 Jul 2022
Scientific Data

Volume: 9, P: 1-22
A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

Larissa Vuitika
Nelson Côrtes
Gustavo Cabral-Miranda
ResearchOpen Access16 Oct 2024
Scientific Reports

Volume: 14, P: 1-17
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study

Luis Felipe Reyes
Alejandro Rodriguez
Neus Guasch
ResearchOpen Access21 Apr 2023
Scientific Reports

Volume: 13, P: 1-15
SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies

Victor Bolsanelli Cioffi
Maria Fernanda de Castro-Amarante
Andrea Balan
ResearchOpen Access05 Oct 2023
Scientific Reports

Volume: 13, P: 1-12

Search

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Unexpected malocclusion in a 13,000-Year-old Late Pleistocene young woman from Mexico

Rare CACNA1H and RELN variants interact through mTORC1 pathway in oligogenic autism spectrum disorder

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective

Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study

SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies

Search

Quick links

Search

Filter By:

Search

Quick links